Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1984 Jun;51(6):589–594. doi: 10.1136/hrt.51.6.589

Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.

M B Murphy, D Sugrue, I Trayner, S Kaufman, H Yasuhara, C T Dollery, G R Thompson
PMCID: PMC481557  PMID: 6732988

Abstract

The effects of beta adrenoceptor blockade with propranolol or pindolol on serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and its subfractions HDL2 and HDL3, serum triglyceride, and Intralipid clearance were studied in 17 normolipidaemic, non-diabetic patients with hypertension or angina pectoris. Both pindolol and propranolol had similar effects on fasting serum total and lipoprotein cholesterol concentrations. HDL2 cholesterol concentrations were reduced by 9 +/- 29% and HDL3 cholesterol increased by 11 +/- 16%, but there were no significant changes in total or LDL cholesterol in the combined groups after six weeks' treatment. After 12 weeks' treatment total cholesterol concentrations were reduced by 7 +/- 10% mainly owing to a reduction in the LDL fraction of 9 +/- 15%. Concentrations of HDL2 remained low, 8% less than control values. Serum triglyceride concentrations were increased by both drugs at six weeks but had returned to base values in the pindolol group by the twelfth week. Pindolol, but not propranolol, enhanced the rate of clearance of intravenous Intralipid.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. W., Nichols A. V., Pan S. S., Lindgren F. T. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis. 1978 Feb;29(2):161–179. doi: 10.1016/0021-9150(78)90005-9. [DOI] [PubMed] [Google Scholar]
  2. Bauer J. H., Brooks C. S., Weinstein I., Wilcox H. H., Heimberg M., Burch R. N., Barkley R. Effects of diuretic and propranolol on plasma lipoprotein lipids. Clin Pharmacol Ther. 1981 Jul;30(1):35–43. doi: 10.1038/clpt.1981.124. [DOI] [PubMed] [Google Scholar]
  3. Birnbaum J., DiBianco R., Becker K. L., Muesing R., Costello R. B., Singh S. N., Gottdiener J. S., Fletcher R. D. Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients. Clin Pharmacol Ther. 1983 Mar;33(3):294–300. doi: 10.1038/clpt.1983.36. [DOI] [PubMed] [Google Scholar]
  4. Bulpitt C. J. Serum uric acid in hypertensive patients. Br Heart J. 1975 Dec;37(12):1210–1215. doi: 10.1136/hrt.37.12.1210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crisp A. J., Kennedy P. G., Hoffbrand B. I., Ebbutt A. F., Carruthers M. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study. Curr Med Res Opin. 1980;7(2):101–103. doi: 10.1185/03007998009112034. [DOI] [PubMed] [Google Scholar]
  6. Day J. L., Metcalfe J., Simpson C. N. Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J (Clin Res Ed) 1982 Apr 17;284(6323):1145–1148. doi: 10.1136/bmj.284.6323.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edmonds C. J., Jasani B. Total-body potassium in hypertension patients during prolonged diuretic therapy. Lancet. 1972 Jul 1;2(7766):8–12. doi: 10.1016/s0140-6736(72)91275-5. [DOI] [PubMed] [Google Scholar]
  8. Elkeles R. S., Khan S. R., Chowdhury V., Swallow M. B. Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci (Lond) 1983 Dec;65(6):669–672. doi: 10.1042/cs0650669. [DOI] [PubMed] [Google Scholar]
  9. Fager G., Berglund G., Bondjers G., Elmfeldt D., Lager I., Olofsson S. O., Smith U., Wiklund O. Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide. Artery. 1983;11(4):283–296. [PubMed] [Google Scholar]
  10. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  11. Gordon T., Kannel W. B., Castelli W. P., Dawber T. R. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med. 1981 Aug;141(9):1128–1131. [PubMed] [Google Scholar]
  12. Helgeland A., Hjermann I., Leren P., Enger S., Holme I. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J. 1978 Aug 5;2(6134):403–403. doi: 10.1136/bmj.2.6134.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  14. Hulley S. B., Rosenman R. H., Bawol R. D., Brand R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 1980 Jun 19;302(25):1383–1389. doi: 10.1056/NEJM198006193022503. [DOI] [PubMed] [Google Scholar]
  15. Johnson B. F. The emerging problem of plasma lipid changes during antihypertensive therapy. J Cardiovasc Pharmacol. 1982;4 (Suppl 2):S213–S221. [PubMed] [Google Scholar]
  16. Khan S. R., Elkeles R. S., Niththyananthan R., Seed M., Wynn V. Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta. 1982 Mar 26;120(1):49–55. doi: 10.1016/0009-8981(82)90076-6. [DOI] [PubMed] [Google Scholar]
  17. Kristensen B. O. Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins. Br Med J (Clin Res Ed) 1981 Jul 18;283(6285):191–192. doi: 10.1136/bmj.283.6285.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Leren P., Foss P. O., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet. 1980 Jul 5;2(8184):4–6. doi: 10.1016/s0140-6736(80)92888-3. [DOI] [PubMed] [Google Scholar]
  19. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  20. Nye E. R., Carlson K., Kirstein P., Rössner S. Changes in high density lipoprotein subfractions and other lipoproteins by exercise. Clin Chim Acta. 1981 Jun 2;113(1):51–57. doi: 10.1016/0009-8981(81)90439-3. [DOI] [PubMed] [Google Scholar]
  21. Patsch J. R., Gotto A. M., Jr, Olivercrona T., Eisenberg S. Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4519–4523. doi: 10.1073/pnas.75.9.4519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SCHOENFELD M. R., GOLDBERGER E. HYPERCHOLESTEROLEMIA INDUCED BY THIAZIDES: A PILOT STUDY. Curr Ther Res Clin Exp. 1964 Mar;6:180–184. [PubMed] [Google Scholar]
  23. Shaw J., England J. D., Hua A. S. Beta-blockers and plasma triglycerides. Br Med J. 1978 Apr 15;1(6118):986–986. doi: 10.1136/bmj.1.6118.986-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tanaka N., Sakaguchi S., Oshige K., Niimura T., Kanehisa T. Effect of chronic administration of propranolol on lipoprotein composition. Metabolism. 1976 Oct;25(10):1071–1075. doi: 10.1016/0026-0495(76)90014-7. [DOI] [PubMed] [Google Scholar]
  25. Taskinen M. R., Välimäki M., Nikkilä E. A., Kuusi T., Ehnholm C., Ylikahri R. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism. 1982 Nov;31(11):1168–1174. doi: 10.1016/0026-0495(82)90169-x. [DOI] [PubMed] [Google Scholar]
  26. Waal-Manning H. J. Metabolic effects of beta-adrenoreceptor blockers. Drugs. 1976;11(Suppl 1):121–126. doi: 10.2165/00003495-197600111-00027. [DOI] [PubMed] [Google Scholar]
  27. Warnick G. R., Albers J. J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978 Jan;19(1):65–76. [PubMed] [Google Scholar]
  28. Zöllner N., Hansen W. A photometric modification of the intravenous fat tolerance test. Atherosclerosis. 1972 May-Jun;15(3):345–348. doi: 10.1016/0021-9150(72)90023-8. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES